Third, to make our conclusion more convincing, the animal study is needed to evaluate the role of INPP4B in vivo, especially whether PI3K inhibitors are more efficient in MM with low INPP4B expression. The gene discussed is INPP4B; the disease is Miyoshi myopathy.